Gelsana Therapeutics
2 known investors
GelSana develops wound dressing products using zwitterionic technology to promote healing in chronic wounds including diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, and burns by reducing inflammation and preventing bacterial infection.